Cardinal Health (CAH) Is Up 2.00% in One Week: What You Should Know
Werte in diesem Artikel
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.While many investors like to look for momentum in stocks, this can be very tough to define. There is a lot of debate surrounding which metrics are the best to focus on and which are poor quality indicators of future performance. The Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us.Below, we take a look at Cardinal Health (CAH), which currently has a Momentum Style Score of A. We also discuss some of the main drivers of the Momentum Style Score, like price change and earnings estimate revisions.It's also important to note that Style Scores work as a complement to the Zacks Rank, our stock rating system that has an impressive track record of outperformance. Cardinal Health currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of "A or B" outperform the market over the following one-month period.You can see the current list of Zacks #1 Rank Stocks here >>> Set to Beat the Market? In order to see if CAH is a promising momentum pick, let's examine some Momentum Style elements to see if this prescription drug distributor holds up.Looking at a stock's short-term price activity is a great way to gauge if it has momentum, since this can reflect both the current interest in a stock and if buyers or sellers have the upper hand at the moment. It's also helpful to compare a security to its industry; this can show investors the best companies in a particular area.For CAH, shares are up 2% over the past week while the Zacks Medical - Dental Supplies industry is up 0.57% over the same time period. Shares are looking quite well from a longer time frame too, as the monthly price change of 29.59% compares favorably with the industry's 3.41% performance as well.While any stock can see a spike in price, it takes a real winner to consistently outperform the market. Over the past quarter, shares of Cardinal Health have risen 41.56%, and are up 73.81% in the last year. In comparison, the S&P 500 has only moved 5.68% and 14.42%, respectively.Investors should also pay attention to CAH's average 20-day trading volume. Volume is a useful item in many ways, and the 20-day average establishes a good price-to-volume baseline; a rising stock with above average volume is generally a bullish sign, whereas a declining stock on above average volume is typically bearish. CAH is currently averaging 2,914,504 shares for the last 20 days.Earnings OutlookThe Zacks Momentum Style Score also takes into account trends in estimate revisions, in addition to price changes. Please note that estimate revision trends remain at the core of Zacks Rank as well. A nice path here can help show promise, and we have recently been seeing that with CAH.Over the past two months, 7 earnings estimates moved higher compared to none lower for the full year. These revisions helped boost CAH's consensus estimate, increasing from $9.45 to $9.86 in the past 60 days. Looking at the next fiscal year, 6 estimates have moved upwards while there have been no downward revisions in the same time period.Bottom LineTaking into account all of these elements, it should come as no surprise that CAH is a #2 (Buy) stock with a Momentum Score of A. If you've been searching for a fresh pick that's set to rise in the near-term, make sure to keep Cardinal Health on your short list.Quantum Computing Stocks Set To SoarArtificial intelligence has already reshaped the investment landscape, and its convergence with quantum computing could lead to the most significant wealth-building opportunities of our time.Today, you have a chance to position your portfolio at the forefront of this technological revolution. In our urgent special report, Beyond AI: The Quantum Leap in Computing Power, you'll discover the little-known stocks we believe will win the quantum computing race and deliver massive gains to early investors.Access the Report Free Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cardinal Health, Inc. (CAH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Cardinal Health und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Cardinal
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Cardinal
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: Zacks
Nachrichten zu Cardinal Health Inc.
Analysen zu Cardinal Health Inc.
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.03.2018 | Cardinal Health Equal Weight | Barclays Capital | |
| 04.12.2017 | Cardinal Health Hold | Deutsche Bank AG | |
| 19.09.2017 | Cardinal Health Sector Perform | RBC Capital Markets | |
| 28.04.2017 | Cardinal Health Neutral | Tigress Financial | |
| 04.04.2017 | Cardinal Health Hold | Needham & Company, LLC |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.11.2015 | Cardinal Health Buy | UBS AG | |
| 03.11.2015 | Cardinal Health Outperform | FBR Capital | |
| 09.06.2015 | Cardinal Health Buy | UBS AG | |
| 10.03.2015 | Cardinal Health Outperform | FBR Capital | |
| 04.03.2015 | Cardinal Health Outperform | RBC Capital Markets |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.03.2018 | Cardinal Health Equal Weight | Barclays Capital | |
| 04.12.2017 | Cardinal Health Hold | Deutsche Bank AG | |
| 19.09.2017 | Cardinal Health Sector Perform | RBC Capital Markets | |
| 28.04.2017 | Cardinal Health Neutral | Tigress Financial | |
| 04.04.2017 | Cardinal Health Hold | Needham & Company, LLC |
| Datum | Rating | Analyst | |
|---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv | |||
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Cardinal Health Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen